References
- 1. W. E. Dismukes, Antifungal therapy: Lessons learned over the past 27 years, Clin. Infect. Dis. 42 (2006) 1289-1296; DOI: 10.1086/503043.10.1086/503043
- 2. R. A. Smith, V. Cokkinides and O. W. Brawley, Cancer screening in the United States, a review of current American Cancer Society guidelines and issues in cancer screening, Cancer J. Clin. 59 (2009) 27-41; DOI: 10.3322/caac.20008.10.3322/caac.20008
- 3. J. B. Bremner, J. I. Ambrus and S. Samosorn, Dual action-based approaches to antibacterial agents, Curr. Med. Chem. 14 (2007) 1459-1477; DOI: 10.2174/092986707780831168.10.2174/092986707780831168
- 4. C. Hubschwerlen, J. L. Specklin, C. Sigwalt, S. Schroeder and H. H. Locher, Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids, Bioorg. Med. Chem. 11 (2003) 2313-2319; DOI: 10.1016/S0968-0896(03)00083-X.10.1016/S0968-0896(03)00083-X
- 5. A. K. Jordao, V. F. Ferreira, E. S. Lima, M. C. de Souza, E. C. Carlos, H. C. Castro, R. B. Geraldo, C. R. Rodrigues, M. C. Almeida and A. C. Cunha, Synthesis, antiplatelet and in silico evaluations of novel N-substituted- phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides, Bioorg. Med. Chem. 17 (2009) 3713-3719; DOI: 10.1016/j.bmc.2009.03.053.10.1016/j.bmc.2009.03.05319380229
- 6. V. Calderone, I. Giorgi, O. Livi, E. Martinotti, E. Mantuano, A. Martelli and A. Nardi, Benzoyl and/ or benzyl substituted 1,2,3-triazoles as potassium channel activators, VIII, Eur. J. Med. Chem. 40 (2005) 521-528; DOI: 10.1016/ j.ejmech.2005.01.010.10.1016/j.ejmech.2005.01.01015922836
- 7. R. F. Pratt, Inhibition of class A beta-lactamase by a specific phosphonate monoester, Science 246 (1989) 917-919; DOI: 10.1126/science.2814513.10.1126/science.28145132814513
- 8. P. Duncanson, Y. K. Cheong, M. Motevalli and D. V. Griffiths, Novel approach to isoindolo[2,1-a] indol-6-ones, Org. Biomol. Chem. 10 (2012) 4266-4279; DOI: 10.1039/C2OB25314C.10.1039/c2ob25314c22526377
- 9. S. Crotty, D. Maag, J. J. Arnold, W. Zhong, J. Y. N. Lau, Z. Hong, R. Andino and C. E. Cameron, The broad spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen, Nature Med. 6 (2000) 1375-1379; DOI: 10.1038/82191.10.1038/8219111100123
- 10. N. Mauras, K. Bishop, D. Merinbaum, U. Emeribe, F. Agbo and E. Lowe, Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia, J. Clin. Endocrinol. Metab. 94 (2009) 2975-2978; DOI: 10.1210/jc.2008-2527.10.1210/jc.2008-252719470631
- 11. W. M. Abdou, M. D. Khidre and R. E. Khidre, Application of phosphonyl carbanions to highly regioselective synthesis of some diazaphospholes and pyrazolinyl phosphonates, Eur. J. Med. Chem. 44 (2009) 526-532; DOI: 10.1016/j. ejmech.2008.03.032.
- 12. W. M. Abdou, N. A. Ganoub and E. Sabry, Synthesis of antimicrobial N-phthaloyl-alanyl-derived amidophosphates and triazoles, Z. Naturforsch. 46b (2009) 1057-1064.10.1515/znb-2009-0911
- 13. W. M. Abdou, A. A. Sediek and M. D. Khidre, An efficient method for the synthesis of spiro and fused N-heterocyclic phosphor esters. Reactions of triketoindan-2-oxime with a-phosphonyl carbanions, Monatsh. Chem. 139 (2008) 617-623; DOI: 10.1007/s00706-007-0806-z.10.1007/s00706-007-0806-z
- 14. W. M. Abdou, R. F. Barghash and A. A. Sediek, Design of new arylamino-2-ethane-1,1-diyl- and benzoxazole-2-methylene-bisphosphonates vs cytotoxicity and chronic inflammation diseases. From hydrophobicity prediction to synthesis and biological evaluation, Eur. J. Med. Chem. 57 (2012) 362-372; DOI: 10.1016/j. ejmech.2012.09.032.
- 15. W. M. Abdou, R. F. Barghash and M. S. Bekheit, Carbodiimides in the synthesis of enamino- and a-aminophosphonates as peptidomimetics of analgesic/antiinflam-matory and anticancer agents, Arch. Pharm. Chem. Life Sci. 345 (2012) 884-895; DOI: 10.1002/ardp.201200142.10.1002/ardp.20120014222930562
- 16. A. A. Kamel, A. Geronikaki and W. M. Abdou, Inhibitory effect of novel S,N-bisphosphonates on some carcinoma cell lines, osteoarthritis and chronic inflammation, Eur. J. Med. Chem. 51 (2012) 239-249; DOI: 10.1016/j.ejmech. 2012.02.047.
- 17. C. H. Da Silva, V. B. Da Silva, J. Resende, P. F. Rodrigues, F. C. Bononi, C. G. Benevenuto and C. A. Taft, Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyl- transferase inhibitors in cancer therapy, J. Mol. Graph. Model. 28 (2010) 513-523; DOI: 10.1016/j. jmgm.2009.11.011.
- 18. A. A. Lagunin, O. A. Gomazkov, D. A. Filimonov, T. A. Gureeva, E. A. Dilakyan, E. V. Kugaevskaya, Y. E. Elisseeva, N. I. Solovyeva and V. V. Poroikov, Computer-aided selection of potential antihypertensive compounds with dual mechanism of action, J. Med. Chem. 46 (2003) 3326-3332; DOI: 10.1021/jm021089h.10.1021/jm021089h12852763
- 19. Y. Bai, G. Zhao, C. Li, S. Zhao and Z. Shi, Microwave-enhanced reactions of 4-amino-5-mercapto-1,2,4-triazoles with benzoyl chloride and aromatic aldehydes, Synth. Commun. 38 (2008) 3311-3319; DOI: 10.1080/00397910802136649.10.1080/00397910802136649
- 20. N. Al-Awadi, Y. Ibrahim, K. Kaul and H. Dib, Gas-phase elimination reactions of 4-arylideneimino-1,2,4-triazol-3(2H)-ones and their 3(2H)-thione analogues, J. Phys. Org. Chem. 14 (2001) 521-525; DOI: 10.1002/poc.383.10.1002/poc.383
- 21. C. Perez, M. Pauli and P. Bazerque, An antibiotic assay by the agar well diffusion method, Acta Biol. Med. Exp. 15 (1990) 113-115.
- 22. A. C. Scott, Laboratory Control of Antimicrobial Therapy, in Mackie and McCartney Practical Medical Microbiology (Eds. J. G. College, J. P. Duguid, A. G. Fraserand and B. P. Marmion), 13th ed., Churchill Livingstone, London 1989, pp. 161-181.
- 23. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing, 17th informational supplement, CLSI document M100-S17, Wayne (PEN) 2007.
- 24. T. Kitamura, M. Itoh, T. Noda, M. Matsuura and K. Wakabayashi, Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice, Int. J. Cancer 109 (2004) 576-580; DOI: 10.1002/ijc.20012.10.1002/ijc.2001214991580
- 25. M. R. Boyd and K. D. Paull, Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen, Drug Dev. Res. 34 (1995) 91-109; DOI: 10.1002/ ddr.430340203.10.1002/ddr.430340203
- 26. J. March, Advanced Organic Chemistry, Reactions, Mechanisms, and Structures, 3rd ed., Wiley, New York 1985, pp. 82-140.
- 27. J. Vinsová, K. Cermáková, A. Tomecková, M. Cecková, J. Jampílek, P. Cermák, J. Kunes, M. Dolezal and F. Staud, Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles, Bioorg. Med. Chem. 14 (2006) 5850-5865; DOI: 10.1016/j.bmc.2006.05.030.10.1016/j.bmc.2006.05.03016784871
- 28. E. S. T. Ali, Synthesis and antibacterial activity of some new thiadiaza/triaza-phospholes, thiadiaza/ triaza/tetraazaphosphinines and thiadiaza/tetraza-phosphepines containing 1,2,4-triazinone moiety, Eur. J. Med. Chem. 44 (2009) 4539-4546; DOI: 10.1016/j.ejmech.2009.06.022.10.1016/j.ejmech.2009.06.02219615792
- 29. H. Lee and R. G. Harvey, 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in acetic acid, a convenient new reagent for the synthesis of aryl ketones and aldehydes via benzylic oxidation, J. Org. Chem. 53 (1988) 4587-4589; DOI: 10.1021/jo00254a035. 10.1021/jo00254a035